Why does cancer relapse, and why it doesn't reflect on scan, at times: Doctor explains

When Arun was told six months ago that his scans showed no signs of cancer, he felt an overwhelming sense of relief. Diagnosed with stage 4 lung cancer, the initial diagnosis had left him in deep shock. However, as treatment progressed, his confidence began to rebuild. Follow-up scans six months later showed no remaining evidence of the tumour, leading Arun to believe he was completely cured. Tragically, recent check-ups brought devastating news—the cancer had returned, leaving him and his family heartbroken and confused.

The fundamental truth about advanced cancer
To understand how a clear scan can be followed by a relapse, it helps to grasp a basic medical fact about oncology. Broadly speaking, cancers fall into two distinct categories: those that can be completely cured, and those that can only be managed over time. In advanced cases, such as stage 4 lung cancer, total eradication is rarely possible, even when initial treatment yields remarkably positive results.

Remission versus recurrence: What the terms really mean
When patients respond exceptionally well to therapy and medical imaging reveals no visible tumours, doctors refer to this state as 'remission', rather than a cure. Remission simply means that the disease is undetectable using current scan technology. However, the battle between therapy and cancer cells is dynamic and continuous. While initial treatment destroys the vast majority of cancer cells, a microscopic handful of resilient cells can enter a dormant state, quietly surviving beneath the detection threshold of standard imaging.

Why cancer comes back stronger
Over time, these lingering cells can adapt, build resistance to earlier treatments, and begin multiplying again. This return of the disease is known as 'recurrence'. When cancer recurs, the new tumours are often more aggressive and resistant to original drug regimens, making subsequent treatment far more challenging.

How oncologists work to delay relapse
This constant threat of relapse is why medical oncologists remain cautiously guarded even when delivering encouraging news. To delay recurrence for as long as possible, medical teams employ specialised maintenance strategies. One common approach is maintenance chemotherapy, where patients receive ongoing lower-dose treatments to keep surviving cells suppressed. Another key strategy is consolidation therapy, which introduces alternative treatment modalities—such as surgery, radiation, or stem cell therapy—to target residual microscopic cells before they can resurface.